JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-28DOI: 10.1016/j.jhlto.2026.100499
Makiko Nakamura , Teruhiko Imamura , Yoshikatsu Saiki , Minoru Ono , Koichiro Kinugawa , on behalf of J-MACS Investigators
{"title":"Recent change in bridging strategy and improved clinical outcomes following durable left ventricular assist device implantation in Japan","authors":"Makiko Nakamura , Teruhiko Imamura , Yoshikatsu Saiki , Minoru Ono , Koichiro Kinugawa , on behalf of J-MACS Investigators","doi":"10.1016/j.jhlto.2026.100499","DOIUrl":"10.1016/j.jhlto.2026.100499","url":null,"abstract":"<div><h3>Background</h3><div>Destination therapy (DT) was approved in Japan in May 2021. Use of Impella device as a bridge to left ventricular assist device (LVAD) implantation has been increasing. The difference of clinical outcomes between Impella-bridge (a conversion from Impella to durable left ventricular assist device [LVAD]), bridge-to-bridge (BTB) (a conversion from extracorporeal LVAD to durable LVAD), and primary LVAD remains unclear especially in Japanese.</div></div><div><h3>Methods</h3><div>Patients who underwent durable LVAD implantation between October 2017 and March 2025 and were prospectively registered in the Japanese Registry for Mechanically Assisted Circulatory Support (J-MACS) were included. The baseline characteristics, cumulative mortality, and adverse events following durable LVAD implantation were retrospectively compared between 2 bridging strategies and primary LVAD cohort.</div></div><div><h3>Results</h3><div>A total of 964 patients who received durable LVAD implantation (median age: 49 years; primary LVAD: 77.4%; Impella-bridge: 11.6%; BTB: 11.0%) were analyzed. The prevalence of Impella-bridge strategy increased especially after DT approval and the introduction of Impella 5.5. The cumulative mortality during durable LVAD support was lowest in Impella-bridge cohort and highest in BTB cohort during a median follow-up of 1053 days (8.0% vs 21.0%). Among the total cohort, an Impella-bridge strategy tended to be associated with a lower mortality following durable LVAD implantation with an adjusted hazard ratio of 0.316 (95% confidence interval 0.095-1.048, <em>p</em> = 0.060).</div></div><div><h3>Conclusions</h3><div>Impella-bridge strategy increased after the introduction of Impella 5.5 in the era of DT and tended to be associated with a lower mortality following durable LVAD implantation. Further studies are warranted to validate the hypothesis.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100499"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-14DOI: 10.1016/j.jhlto.2026.100487
Sajjad Ali , Robin High , Marian Urban , David Axelrod , Steven Potter , Aleem Siddique
{"title":"Expedited Lung Allocation in The Era of Continuous Distribution","authors":"Sajjad Ali , Robin High , Marian Urban , David Axelrod , Steven Potter , Aleem Siddique","doi":"10.1016/j.jhlto.2026.100487","DOIUrl":"10.1016/j.jhlto.2026.100487","url":null,"abstract":"<div><h3>Background</h3><div>The frequency of use of expedited offers in lung allocation has increased.</div></div><div><h3>Methods</h3><div>This study retrospectively analyzed lung offers accepted for transplant in the United States for the period from the introduction of continuous distribution in allocation in March 2023 to March 2024 to identify characteristics of donors, recipients, and offers associated with expedited placement. Data were obtained from the Scientific Registry of Transplant Recipients and categorized by expedited vs non-expedited offers.</div></div><div><h3>Results</h3><div>Of the 3,136 lung organ offers transplanted, 9% (284) were expedited. Expedited offers were more likely for male donors with blood type O, while recipients were typically older, male, non-Hispanic, and diagnosed with lung condition category A. These recipients also demonstrated lower composite allocation and medical urgency scores, and were less likely to be hospitalized, ventilated, or on extracorporeal life support. Time on the waitlist and post-transplant 30-day survival rates were similar between expedited and non-expedited groups. One-year survival was higher in recipients of expedited lung placements. Expedited offers had a median sequence number at acceptance of 83.5, bypassing a median of 54.5 listed patients, and were more often placed at centers with higher offer acceptance ratios.</div></div><div><h3>Conclusion</h3><div>Expedited placements are associated with lower-acuity recipients. Further policy reform should aim to ensure equity while optimizing organ placement and recipient outcomes.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100487"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"First implantation of a bioprosthetic total artificial heart for a mediastinal paraganglioma","authors":"Ali Akamkam MD, MSc , Marie-Eve Garcia MD , Elie Fadel MD, PhD , Julien Guihaire MD, PhD","doi":"10.1016/j.jhlto.2026.100485","DOIUrl":"10.1016/j.jhlto.2026.100485","url":null,"abstract":"<div><div>Resection of cardiac-invasive tumors is challenging, as transplantation is not a viable option for patients with cancer. We report the first implantation of the Aeson total artificial heart (TAH) (Carmat, Vélizy-Villacoublay, France), as a bridge to transplant in a patient with a mediastinal paraganglioma. A 54-year-old man presented with restrictive heart failure related to a paraganglioma. The tumor was invading the right ventricle. No tumor reduction was achieved after chemotherapy. A surgical resection of the tumor combined with the implantation of the Aeson TAH was decided. Embolization of the nutrient vessels of the tumor was performed before surgery to decrease hemorrhagic risk. A positron emission tomography scan at 3 months showed no tumor recurrence. The patient was transplanted 6 months after TAH implantation. No severe primary graft dysfunction or acute rejection was observed. However, the patient developed refractory vasoplegia, which ultimately led to multiorgan failure and death 6 months after transplantation.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100485"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146081934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-12DOI: 10.1016/j.jhlto.2026.100486
Salem T. Argaw , Ali Akamkam , Sébastien Hascoet , Stéphan Haulon , Julien Guihaire MD, PhD
{"title":"A 3-stage hybrid strategy for heart transplantation following ascending-to-descending aortic bypass grafting","authors":"Salem T. Argaw , Ali Akamkam , Sébastien Hascoet , Stéphan Haulon , Julien Guihaire MD, PhD","doi":"10.1016/j.jhlto.2026.100486","DOIUrl":"10.1016/j.jhlto.2026.100486","url":null,"abstract":"<div><div>Cardiac reoperation after an extra-anatomic aortic bypass graft entails considerable risk due to the proximity of the graft to the sternum. In the case discussed here, a woman with 2 prior sternotomies and a retrosternal aortic bypass graft for a history of aortic coarctation presented with advanced dilated cardiomyopathy requiring heart transplantation. The patient was managed through a novel 3-stage hybrid strategy. In the first stage, a catheter-based approach was used to stent the coarcted aorta. Subsequently, the extra-anatomic graft was endovascularly excluded and, finally, the patient underwent reoperation for heart transplantation. The use of interdisciplinary collaboration for coordinated staging and shared decision-making, as in this case, allows for innovative solutions and improved outcomes in complex surgical needs.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100486"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146184044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-15DOI: 10.1016/j.jhlto.2026.100491
Doug A. Gouchoe MD , Ashley Cardenas MAS, FAST , Gary F. Marklin MD, MA , Errol Bush MD , Bryan A. Whitson MD, PhD , Jordan R.H. Hoffman MD, MPH , Darren Stewart MS , David A. Axelrod MD, MBA , Aleem Siddique MBBS, FACS, FACC
{"title":"Promoting utilization of donors after circulatory death in lung transplantation","authors":"Doug A. Gouchoe MD , Ashley Cardenas MAS, FAST , Gary F. Marklin MD, MA , Errol Bush MD , Bryan A. Whitson MD, PhD , Jordan R.H. Hoffman MD, MPH , Darren Stewart MS , David A. Axelrod MD, MBA , Aleem Siddique MBBS, FACS, FACC","doi":"10.1016/j.jhlto.2026.100491","DOIUrl":"10.1016/j.jhlto.2026.100491","url":null,"abstract":"<div><div>Lungs recovered from donation after circulatory death (DCD) are markedly underutilized for transplantation in the U.S. Evidence demonstrating excellent outcomes after DCD lung transplantation underpins the need for strategies to mitigate barriers to DCD lung utilization, including data driven revisions to allocation policy, revising program-specific quality metrics, removing financial barriers, and minimizing logistical disincentives. Expanded DCD transplantation is vital to reduce waitlist mortality and increase lung transplant rate.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100491"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-13DOI: 10.1016/j.jhlto.2026.100482
Adam Lowe MD , S. Travis King PharmD , Jonathan Hand MD
{"title":"The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us","authors":"Adam Lowe MD , S. Travis King PharmD , Jonathan Hand MD","doi":"10.1016/j.jhlto.2026.100482","DOIUrl":"10.1016/j.jhlto.2026.100482","url":null,"abstract":"<div><div>Patients with mechanical circulatory support (MCS) devices and those who undergo heart transplants are at risk for invasive fungal infections (IFI). Though <em>Candida</em> and <em>Aspergillus spp.</em> account for most infections, the evolving epidemiology of resistant-<em>Candida spp</em>. such as <em>Candida auris</em>, endemic mycoses, and other molds impacted by climate change, threaten MCS and transplant patients. Fungal diagnostics are overall limited, and current, widely used antifungal agents are suboptimal with significant toxicities. However, innovative diagnostic strategies coupled with novel antifungal agents for prevention and treatment of invasive fungal disease encourage optimism for MCS and transplant patients and clinicians.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100482"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146057389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-20DOI: 10.1016/j.jhlto.2026.100496
Rossella Loria , Antonio Giuseppe Bianculli , Paola Giustiniani , Maria Troiano , Marco Andreani , Giorgia Grutter
{"title":"MicroRNAs and their role in heart transplantation insights into rejection mechanisms: A narrative review","authors":"Rossella Loria , Antonio Giuseppe Bianculli , Paola Giustiniani , Maria Troiano , Marco Andreani , Giorgia Grutter","doi":"10.1016/j.jhlto.2026.100496","DOIUrl":"10.1016/j.jhlto.2026.100496","url":null,"abstract":"<div><div>Heart transplantation is the definitive treatment for patients with advanced heart failure and refractory symptoms. However, allograft rejection—both acute and chronic—remains a major cause of morbidity, leading to graft dysfunction and failure. Traditionally, endomyocardial biopsy (EMB) has been the standard method for screening allograft rejection. MicroRNAs (miRNAs) are small, non-coding RNA sequences that regulate gene expression by binding to the 3' untranslated regions of complementary mRNA transcripts. This review explores the potential of miRNAs as biomarkers for detecting allograft rejection in heart transplant recipients. MiRNAs may serve as non-invasive “liquid biopsies,” providing a novel approach to monitor and manage post-transplant patients.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100496"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-17DOI: 10.1016/j.jhlto.2026.100492
Antoine Premachandra MD , Jacob Klapper MD , Jonathan Messika MD, PhD , Maira Gaillard MD , Martin Kloeckner MD , Kamrouz Ghadimi MD, MHSc , Matthieu Reffienna PT , Krista Ingle PhD , Kirti Magudia MD , Brandi Bottiger MD
{"title":"Frailty assessment and candidate optimization before cardiothoracic transplantation","authors":"Antoine Premachandra MD , Jacob Klapper MD , Jonathan Messika MD, PhD , Maira Gaillard MD , Martin Kloeckner MD , Kamrouz Ghadimi MD, MHSc , Matthieu Reffienna PT , Krista Ingle PhD , Kirti Magudia MD , Brandi Bottiger MD","doi":"10.1016/j.jhlto.2026.100492","DOIUrl":"10.1016/j.jhlto.2026.100492","url":null,"abstract":"<div><div>Frailty is an important syndrome in an aging thoracic transplant population, particularly in the context of end-stage cardiopulmonary disease. In this review, we discuss the core problem of lack of physiologic reserve in these patients and its relationship to perioperative outcomes, how to define and measure frailty in the context of heart and lung transplant and identify interventions to treat contributors to this clinical syndrome. We highlight the critical need in the transplant community to identify and treat these conditions prior to their transplantation and to prevent comorbidity and mortality.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100492"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-04-23DOI: 10.1016/j.jhlto.2026.100553
Keerthana Sankar MD , Laura DiChiacchio MD, PhD , Yuri Matusov MD , Pedro Catarino MD , Dominick Megna MD , Lorenzo Zaffiri MD, PhD , Jeremy Falk MD , Peter Chen MD , Reinaldo Rampolla MD
{"title":"Machine learning analysis identifies key predictors of baseline lung allograft dysfunction and increased mortality in lung transplant patients","authors":"Keerthana Sankar MD , Laura DiChiacchio MD, PhD , Yuri Matusov MD , Pedro Catarino MD , Dominick Megna MD , Lorenzo Zaffiri MD, PhD , Jeremy Falk MD , Peter Chen MD , Reinaldo Rampolla MD","doi":"10.1016/j.jhlto.2026.100553","DOIUrl":"10.1016/j.jhlto.2026.100553","url":null,"abstract":"<div><h3>Background</h3><div>Baseline lung allograft dysfunction (BLAD) is a phenotype of early graft dysfunction associated with impaired survival after lung transplantation. Although prior work links BLAD with several pre- and post-transplant factors, a robust set of donor and recipient predictors remains unclear.</div></div><div><h3>Research Question</h3><div>What are important donor and recipient predictors of BLAD?</div></div><div><h3>Methods</h3><div>We retrospectively reviewed 124 adults who underwent bilateral lung transplantation at a single center. Donor and recipient variables were evaluated using machine learning (gradient boosting and classification tree models), with high-importance predictors incorporated into logistic regression. Survival was assessed using Kaplan-Meier and Cox proportional hazards models.</div></div><div><h3>Results</h3><div>BLAD occurred in 58 of 124 patients (46.7%). Our analysis identified 7 key factors associated with BLAD: Increased cold ischemia time (<em>p</em> = 0.04) and extremes of Body Mass Index (BMI) (p = 0.04) were associated with BLAD in a non-linear manner. Increased post-transplant Intensive Care Unit (ICU) length of stay (Odds Ratio [OR]: 1.08, 95% Confidence Interval [CI]: 1.00-1.17, <em>p</em> = 0.04) and donor tobacco use > 20 pack years (OR: 16.83, 95% CI: 2.34-121.2, <em>p</em> = 0.005) were also associated with higher odds of BLAD. Female sex (OR: 0.08, 95% CI: 0.02-0.39, <em>p</em> = 0.002), older age (OR: 0.93, 95% CI: 0.88-0.97, <em>p</em> = 0.003), and higher pre-operative Forced Expiratory Volume in 1 second (FEV₁) (OR: 0.19, 95% CI: 0.07-0.55, <em>p</em> = 0.002) were associated with lower odds of BLAD. The model demonstrated strong predictive performance (C-index 0.79, cross-validated). Patients with moderate to severe BLAD (Grade 2 and 3) had a significantly increased risk of death over a median follow-up period of 815 days (Hazard Ratio [HR] 3.53, 95% CI: 1.07-11.71, <em>p</em> = 0.04).</div></div><div><h3>Conclusions</h3><div>BLAD is common after bilateral lung transplantation. Moderate to severe BLAD is associated with worse survival. Machine learning identified biological variables associated with BLAD and modifiable peri-operative variables, highlighting opportunities for pre-transplant and intra-operative optimization.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100553"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147995443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-05-01Epub Date: 2026-01-23DOI: 10.1016/j.jhlto.2026.100497
Anh Nguyen MD, PhD , Abbas Rana MD , Alexis Shafii MD , Gabriel Loor MD , Andrew Civitello MD , Todd Rosengart MD , Kenneth Liao MD, PhD
{"title":"Risk factors when considering heart transplants with donors aged 45 or above: Development of a Novel Mortality Risk Score using UNOS data","authors":"Anh Nguyen MD, PhD , Abbas Rana MD , Alexis Shafii MD , Gabriel Loor MD , Andrew Civitello MD , Todd Rosengart MD , Kenneth Liao MD, PhD","doi":"10.1016/j.jhlto.2026.100497","DOIUrl":"10.1016/j.jhlto.2026.100497","url":null,"abstract":"<div><h3>Background</h3><div>Current International Society for Heart and Lung Transplantation guidelines support the use of donor hearts aged ≥45 if significant coronary artery disease is excluded and ischemic time remains <4 hours. This study aimed to identify additional risk factors affecting patient survival and develop a risk score for recipients of older donor hearts.</div></div><div><h3>Methods</h3><div>We performed a retrospective cohort study of adult heart transplants using donors aged ≥45 from January 2000 to June 2024, using United Network for Organ Sharing data. Multivariable Cox regression identified risk factors for mortality, and the most significant variables were used to construct a risk score.</div></div><div><h3>Results</h3><div>Of 58,859 adult heart transplants, 9,843 (16.7%) involved donors aged ≥45. Recipient median age was 58 years (interquartile range, 51-64). One-, 5-, and 10-year patient survival rates were 87.0%, 73.3%, and 53.5%, respectively. Statistically significant risk factors included ischemic time ≥4 hours (HR = 1.11), cytomegalovirus (CMV)-positive donor status (hazard ratio [HR] = 1.11), donor cigarette use (HR = 1.10) and recipient factors: age >55 (HR = 1.37), Black race (HR = 1.19), obesity (HR = 1.20), diabetes (HR = 1.27), pretransplant dialysis (HR = 1.44), pretransplant mechanical ventilator use (HR = 1.37), and prior cardiac surgery (HR = 1.28). Model discrimination was moderate with C-statistics of 0.58.</div></div><div><h3>Conclusions</h3><div>When considering heart transplants with donors aged ≥45, we should screen for ischemic time ≥4 hours, CMV-positive donor, donor cigarette use, and the following recipient factors: age >55, Black race, obesity, diabetes, pretransplant dialysis or mechanical ventilation, and prior cardiac surgery.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"12 ","pages":"Article 100497"},"PeriodicalIF":0.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146190239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}